Revenue
No reported data
Rezolute, Inc. (RZLT)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2023
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 · Dec 31 | 2011 · Jun 30 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & development | $61.5M | $55.7M | $43.8M | $32.5M | $15.0M | $14.4M | $19.1M | $17.3M | $12.1M | $9.4M | $4.7M | $34,317 | $3,494 | $24,500 | $0 | $24,500 |
| Operating expenses | $79.9M | $70.4M | $56.0M | $41.8M | $22.9M | $20.5M | $25.9M | $28.7M | $20.3M | $15.0M | $10.7M | $5.2M | $6.1M | $91,214 | $392,976 | $41,927 |
| Operating income | −$79.9M | −$70.4M | −$56.0M | −$41.8M | −$22.9M | −$20.5M | −$25.9M | −$28.7M | −$20.3M | −$15.0M | −$10.7M | −$5.2M | −$6.1M | — | −$392,976 | — |
| EBITDAderived | −$79.9M | −$70.4M | −$56.0M | −$41.8M | −$22.9M | −$20.5M | −$25.9M | −$27.7M | −$19.2M | −$14.2M | −$10.6M | −$5.2M | −$6.1M | — | — | — |
| Net income | −$74.4M | −$68.5M | −$51.8M | −$41.1M | −$20.9M | −$20.3M | −$30.4M | −$29.9M | −$20.3M | −$14.9M | −$11.4M | −$9.7M | −$6.7M | −$91,214 | −$590,215 | −$41,927 |
| Basic EPSper diluted share | -$0.98 | -$1.33 | -$1.01 | -$2.26 | -$2.72 | -$3.54 | -$18.41 | -$0.54 | -$0.57 | -$0.84 | -$0.54 | -$1.04 | -$1.08 | -$0.03 | -$0.02 | -$0.01 |
| Diluted EPSper diluted share | -$0.98 | -$1.33 | -$1.01 | -$2.32 | -$2.72 | -$3.54 | -$18.41 | -$0.54 | -$0.57 | -$0.84 | -$0.54 | -$1.04 | -$1.08 | -$0.03 | -$0.02 | -$0.01 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 30, 2026Form 4 | Evans DaronCFO | BuyCommon Shares | 10.0K | $2.85 | $28.5K | 414.5K |
| Dec 16, 2025Form 4 | Hogenhuis WladimirDirector | BuyCommon Shares | 5.7K | $1.69 | $9.5K | 119.7K |
| Dec 16, 2025Form 4 | ROBERTS BRIAN KENNETHChief Medical Officer | BuyCommon Shares | 28.0K | $1.70 | $47.6K | 308.4K |
| Dec 15, 2025Form 4 | Evans DaronCFO | BuyCommon Shares · indirect | 2.5K | $1.79 | $4.5K | 7.0K |
| Dec 15, 2025Form 4 | Evans DaronCFO | BuyCommon Shares · indirect | 2.5K | $1.79 | $4.5K | 7.0K |